A wide variety of nanotechnological devices for the treatment of infectious diseases have been developed, including microemulsions, vaccines, and metallic- inorganic-lipid- and polymeric-based nanoparticles.

Metallic NPs such as silver (AgNP) and gold (AuNP) show unique and considerably distinct physical, chemical, and biological properties due to their high surface-to-volume ratio, with which surfaces can be modified with ligands containing functional groups, providing an electrostatic or steric stabilization.

Attached below is a 10 page 2017 Research Article published by Hindawi Journal of Nanomaterials on this subject of nanoparticle technology.

It is rather technical but it concludes:

“Currently, an intense investigation in nanotechnology and its applications in infectious or contagious diseases has led to the development of antimicrobial formulations from nanoparticles that act as an effective bactericidal agent. In this study, it was demonstrated that an increase in the antibacterial activity against Gram-negative bacteria appears when silver nanoparticles are capped with the UBI antimicrobial peptide, probably due to the multimeric or polyvalent arrangement of ligands distributed on the nanoparticle surface. Additional studies are required to understand the structure of multivalent nanoparticles and stabilization mechanisms not yet elucidated”.

You can read or download the Article by CLICKING HERE